Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid in pediatric epilepsy surgery
ChiCTR-IPR-17014033Phase 4Recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in epilepsy (2 arms), sponsored by Xuanwu Hospital. Primary endpoints: Blood coagulation substances infusion rate and Proportion of patients who were transfused with allogeneic blood. Started Dec 2017; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
epilepsy
Beyond the preview
Go deeper on ChiCTR-IPR-17014033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17014033.